| AEs | Adverse Events |
| AIC | Akaike Information Criterion |
| CCI | Charlson Comorbidity Index |
| CI | Confidence Interval |
| CRT | Chemoradiotherapy |
| CTCAEs | Common Terminology Criteria for Adverse Events |
| HR | Hazard Ratio |
| KPS | Karnofsky Performance Status |
| NSCLC | Non-Small-Cell Lung Cancer |
| OS | Overall Survival |
| PACIFIC | Durvalumab Phase III Trial in Stage III NSCLC |
| PD-L1 | Programmed Death-Ligand 1 |
| PFS | Progression-Free Survival |
| RT | Radiotherapy |
| UICC | Union for International Cancer Control |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.